Bach Option’s Biogen BIIB Stock Holding History

Bach Option’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,566	Closed	-$471K	–	91
2018 Q4	$471K	Buy	+1,566	New	+$500K	0.12%	102
2018 Q3	–	Sell	-1,148	Closed	-$333K	–	115
2018 Q2	$333K	Sell	1,148 -32	-3%	-$9K	0.16%	77
2018 Q1	$323K	Buy	+1,180	New	+$366K	0.18%	58

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bach Option's BIIB Position: Q1 2019 in Review

Bach Option sold out of Biogen (BIIB) in Q1 2019, closing a stake of 1,566 shares — an estimated $471K sold.

Bach Option first reported a position in BIIB in Q1 2018 and held it in 3 quarters. The position peaked at $471K in Q4 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Bach Option reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Bach Option sold 1,566 Biogen shares in Q1 2019, an estimated $471K.
Bach Option first reported a position in Biogen in Q1 2018 and held it in 3 quarters.
Bach Option's Biogen position peaked at $471K in Q4 2018.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Bach Option's 13F filing for Q1 2019, filed 12 Apr 2019.